November 22, 2010
Posted by admin
Advanced Cell Technology Receives FDA Clearance For the First Clinical Trial Using Embryonic Stem Cells to Treat Macular Degeneration.
FDA Lifts Clinical Hold; Company to Commence a Phase I/II Clinical Trial at Multiple Centers MARLBOROUGH, MA– November 22, 2010.
Advanced Cell Technology, Inc. (“ACT”; OTCBB:ACTC) announced today that the US Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal [...]